Pharmac asked to reconsider funding RSV drug for at-risk babies stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
Paediatricians and neonatal experts are pleading with Pharmac to rethink its decision to stop funding a drug that prevents at-risk babies from being hospitalised with a deadly lung infection.
Caroline A. Crowther and colleagues investigate whether tighter or less tight glycaemic targets for women with gestational diabetes mellitus reduce maternal and perinatal morbidity in New Zealand.
The grants announced on 30 June include:Professor Alistair Gunn, Faculty of Medical and Health SciencesPathogenesis, detection and treatment of perinatal brain injury60 months $4,999,982.55Perinatal brain injury is the single greatest cause of disabi
A renowned research team whose work has helped millions of babies and mums around the world has landed New Zealand's premier science award.
This year's $5